Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Invo Bioscience Inc (INVO)

Invo Bioscience Inc (INVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,173
  • Shares Outstanding, K 3,809
  • Annual Sales, $ 3,020 K
  • Annual Income, $ -8,030 K
  • EBIT $ -5 M
  • EBITDA $ -4 M
  • 60-Month Beta 1.43
  • Price/Sales 1.11
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.74
  • Most Recent Earnings $-0.62 on 08/14/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.20
  • Growth Rate Est. (year over year) +23,885.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6311 +31.99%
on 10/11/24
1.4200 -41.34%
on 10/14/24
+0.1379 (+19.84%)
since 09/20/24
3-Month
0.6311 +31.99%
on 10/11/24
1.4200 -41.34%
on 10/14/24
+0.0860 (+11.51%)
since 07/19/24
52-Week
0.6300 +32.22%
on 11/09/23
3.5000 -76.20%
on 04/17/24
+0.2930 (+54.26%)
since 10/20/23

Most Recent Stories

More News
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma

INVO : 0.8330 (-2.91%)
NAYA : 0.7500 (-1.32%)
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences

INVO : 0.8330 (-2.91%)
NAYA : 0.7500 (-1.32%)
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

INVO : 0.8330 (-2.91%)
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END

TCBP : 0.6600 (+0.15%)
CVM : 0.7299 (-4.60%)
INVO : 0.8330 (-2.91%)
SNY : 47.71 (+0.44%)
PFE : 26.36 (+2.29%)
INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company") today announced that its special meeting of shareholders on September 29, 2023...

INVO : 0.8330 (-2.91%)
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

INVO : 0.8330 (-2.91%)
INVO Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

INVO : 0.8330 (-2.91%)
INVO Closes Acquisition of Wisconsin Fertility Institute

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

INVO : 0.8330 (-2.91%)
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with...

INVO : 0.8330 (-2.91%)
INVO Bioscience Announces Closing of $4.5 Million Public Offering

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

INVO : 0.8330 (-2.91%)

Business Summary

INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility...

See More

Key Turning Points

3rd Resistance Point 0.9355
2nd Resistance Point 0.9077
1st Resistance Point 0.8704
Last Price 0.8330
1st Support Level 0.8053
2nd Support Level 0.7775
3rd Support Level 0.7402

See More

52-Week High 3.5000
Fibonacci 61.8% 2.4037
Fibonacci 50% 2.0650
Fibonacci 38.2% 1.7263
Last Price 0.8330
52-Week Low 0.6300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar